1 / 5

Europe Cell Line Development Market may exceed USD 2.1 billion by 2024

Increasing prevalence of chronic diseases such as cancer will drive the Europe cell line development market. Cancer is one of the leading causes of morbidity and mortality in Europe. Extensive investment in R&D activities to reduce cancer burden in the region, will fuel need for cell line development for cancer treatment.

madhurip3918
Download Presentation

Europe Cell Line Development Market may exceed USD 2.1 billion by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Europe Cell Line Development Market to reach USD 2.1bn by 2024: Graphical Research ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  2. Key Insights from Europe Cell Line DevelopmentMarket: • Graphical Research says, Europe Cell Line Development Market to reach USD 2.1bn by 2024 • Growing disease burden across the globe is the key factor that will drive cell line development market growth. • Rising demand for vaccines and monoclonal antibodies in treatment of cancer, autoimmune diseases and anti-inflammatory disease will fuel demand for cell line cultures. • Developments in biotechnology industry, increasing healthcare expenditure coupled with growing adoption of technologically advanced products should accelerate the cell line development industry growth. • Technological advancements in cell line development products is another major contributor for cell line development business growth. Availability of automated screening methods, enriched medias, disposable equipment and improved expression systems for enhancing cell line development practices will foster market growth. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  3. Continued... • Reagents and media product segment accounted for largest market share of 53.6% in 2017 and is projected to show robust growth throughout the analysis period. • Mammalian cell cultures segment was valued at USD 650.8 million in 2017 and is estimated to show similar growth during the forecast period. • Recombinant cell line type segment is anticipated to grow at 12.5% CAGR during the forthcoming years. Advent of rDNA technology has drastically increased the demand for recombinant cell lines • Germany cell line development market will grow considerably during the forecast period owing to increasing disease burden in the region. Growing adoption of vaccines and monoclonal antibodies will foster cell line development industry growth. • Key industry players operating in Europe cell line development market are Selexis, Sartorius, Lonza Group, Samsung Biologics, WuXiAppTec, GE Healthcare, Thermo Fisher Scientific, The European Collection of Cell Cultures, Sigma-Aldrich (Merck), GVK BIO, and Progenitor Cell Therapy. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  4. Browse Full Market Research Report On Europe Cell Line Development Market @ https://bit.ly/2N4VHQC Request for a Sample of this Research Report @ https://bit.ly/2zs5k88 ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  5. Stay In Touch With Us For: Website: www.graphicalresearch.com Social Media: Assured Quality On-Time Delivery Payment Security Industry Experts ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

More Related